Associated Papers
IFNAR2 p.F8S Variant Associates with Severe COVID-19 and Adaptive Immune Cell Activation Modulation.
Malvestiti F et al.
International Journal of Molecular Sciences, 2026
Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma.
Linder A et al.
Human Reproduction (oxford, England), 2024
Case report: Two unique nonsense mutations in HTRA1-related cerebral small vessel disease in a Chinese population and literature review.
Chen W et al.
Frontiers in Neurology, 2022
An emerging spectrum of variants and clinical features in KCNMA1-linked channelopathy.
Miller JP et al.
Channels (austin, Tex.), 2021
Pharmacogenomics of Hypertension Treatment.
Rysz J et al.
International Journal of Molecular Sciences, 2020
Statistical analysis of disease-causing and neutral mutations in human membrane proteins.
Kulandaisamy A et al.
Proteins, 2019
Pharmacogenomic studies of hypertension: paving the way for personalized antihypertensive treatment.
Eadon MT et al.
Expert Review of Precision Medicine and Drug Development, 2018
Association between potassium channel SNPs and essential hypertension in Xinjiang Kazak Chinese patients.
Han YY et al.
Experimental and Therapeutic Medicine, 2017
Exome Sequencing Identifies a Novel LMNA Splice-Site Mutation and Multigenic Heterozygosity of Potential Modifiers in a Family with Sick Sinus Syndrome, Dilated Cardiomyopathy, and Sudden Cardiac Death.
Zaragoza MV et al.
Plos One, 2016
An update on the pharmacogenetics of treating hypertension.
Fontana V et al.
Journal of Human Hypertension, 2015
Genome-wide association study of kidney function decline in individuals of European descent.
Gorski M et al.
Kidney International, 2015
BK channel activation by tungstate requires the β1 subunit extracellular loop residues essential to modulate voltage sensor function and channel gating.
Fernández-Mariño AI et al.
Pflugers Archiv : European Journal of Physiology, 2014
Single-nucleotide polymorphisms in vascular Ca2+-activated K+-channel genes and cardiovascular disease.
Köhler R
Pflugers Archiv : European Journal of Physiology, 2010
PhenoHM: human-mouse comparative phenome-genome server.
Sardana D et al.
Nucleic Acids Research, 2010
Common charge-shift mutation Glu65Lys in K+ channel β₁-Subunit KCNMB1: pleiotropic consequences for glomerular filtration rate and progressive renal disease.
Chen Y et al.
American Journal of Nephrology, 2010
Has pharmacogenetics brought us closer to 'personalized medicine' for initial drug treatment of hypertension?
Arnett DK et al.
Current Opinion in Cardiology, 2009
Association of candidate gene polymorphisms with chronic kidney disease in Japanese individuals with hypertension.
Yoshida T et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension, 2009
Association of genetic variants with chronic kidney disease in Japanese individuals with type 2 diabetes mellitus.
Yoshida T et al.
International Journal of Molecular Medicine, 2009
The KCNMB1 E65K variant is associated with reduced central pulse pressure in the community-based Framingham Offspring Cohort.
Kelley-Hedgepeth A et al.
Journal of Hypertension, 2009
The KCNMB1 Glu65Lys polymorphism associates with reduced systolic and diastolic blood pressure in the Inter99 study of 5729 Danes.
Nielsen T et al.
Journal of Hypertension, 2008
Genetic variation in the KCNMA1 potassium channel alpha subunit as risk factor for severe essential hypertension and myocardial infarction.
Tomás M et al.
Journal of Hypertension, 2008
An african-specific functional polymorphism in KCNMB1 shows sex-specific association with asthma severity.
Seibold MA et al.
Human Molecular Genetics, 2008
Genetic factors for ischemic and hemorrhagic stroke in Japanese individuals.
Yamada Y et al.
Stroke, 2008
Interactions among genetic variants from contractile pathway of vascular smooth muscle cell in essential hypertension susceptibility of Chinese Han population.
Zhao Q et al.
Pharmacogenetics and Genomics, 2008
Association of a polymorphism of CYP3A4 with type 2 diabetes mellitus.
Yamada Y et al.
International Journal of Molecular Medicine, 2007
KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST).
Beitelshees AL et al.
Pharmacogenetics and Genomics, 2007
Single nucleotide polymorphism discovery and haplotype analysis of Ca2+-dependent K+ channel beta-1 subunit.
Gong Y et al.
Pharmacogenetics and Genomics, 2007
Rarity of Somatic Mutation and Frequency of Normal Sequence Variation Detected in Sporadic Colon Adenocarcinoma Using High-Throughput cDNA Sequencing.
Kan T et al.
Bioinformatics and Biology Insights, 2007
Protective effect of the KCNMB1 E65K genetic polymorphism against diastolic hypertension in aging women and its relevance to cardiovascular risk.
Sentí M et al.
Circulation Research, 2005
The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview.
Ferraro TN et al.
Epilepsy & Behavior : E&b, 2005
Association analysis between hypertension and CYBA, CLCNKB, and KCNMB1 functional polymorphisms in the Japanese population--the Suita Study.
Kokubo Y et al.
Circulation Journal : Official Journal of the Japanese Circulation Society, 2005
Gain-of-function mutation in the KCNMB1 potassium channel subunit is associated with low prevalence of diastolic hypertension.
Fernández-Fernández JM et al.
The Journal of Clinical Investigation, 2004